Proteomics Study Reveals That Docosahexaenoic and Arachidonic Acids Exert Different In Vitro Anticancer Activities in Colorectal Cancer Cells

• Published in: Journal of agricultural and food chemistry Vol. 66; no. 24; pp. 6003 - 6012
• Main Authors: Ortea, Ignacio, González-Fernández, María José, Ramos-Bueno, Rebeca P, Guil-Guerrero, José Luis
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 20-06-2018
• Subjects: ARA; colorectal cancer; SWATH; proteomics; DHA; PUFA
• ISSN: 0021-8561; 1520-5118
• DOI: 10.1021/acs.jafc.8b00915

Two polyunsaturated fatty acids, docosahexaenoic acid (DHA) and arachidonic acid (ARA), as well as derivatives, such as eicosanoids, regulate different activities, affecting transcription factors and, therefore, DNA transcription, being a critical step for the functioning of fatty-acid-derived signaling. This work has attempted to determine the in vitro anticancer activities of these molecules linked to the gene transcription regulation of HT-29 colorectal cancer cells. We applied the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test along with lactate dehydrogenase and caspase-3 assays; proteome changes were assessed by “sequential windowed acquisition of all theoretical mass spectra” quantitative proteomics, followed by pathway analysis, to determine the affected molecular mechanisms. In all assays, DHA inhibited cell proliferation of HT-29 cells to a higher extent than ARA and acted primarily by downregulating proteasome particles, while ARA presented a dramatic effect on all six DNA replication helicase particles. The results indicated that both DHA and ARA are potential chemopreventive agent candidates.